These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 29547445)

  • 1. Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa.
    Kroeze S; Ondoa P; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Boender TS; de Pundert ME; Sigaloff KCE; Reiss P; Wit FWNM; Rinke de Wit TF; Hamers RL
    AIDS; 2018 May; 32(8):1043-1051. PubMed ID: 29547445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and impact of suboptimal immune recovery on first-line antiretroviral therapy within the International Epidemiologic Databases to Evaluate AIDS in East Africa.
    Nakanjako D; Kiragga AN; Musick BS; Yiannoutsos CT; Wools-Kaloustian K; Diero L; Oyaro P; Lugina E; Ssali JC; Kambugu A; Easterbrook P
    AIDS; 2016 Jul; 30(12):1913-22. PubMed ID: 26959510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era.
    Roul H; Mary-Krause M; Ghosn J; Delaugerre C; Pialoux G; Cuzin L; Launay O; Lacombe JM; Menard A; De Truchis P; Delfraissy JF; Weiss L; Costagliola D;
    AIDS; 2018 Nov; 32(17):2605-2614. PubMed ID: 30289817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term HIV treatment outcomes and associated factors in sub-Saharan Africa: multicountry longitudinal cohort analysis.
    Inzaule SC; Kroeze S; Kityo CM; Siwale M; Akanmu S; Wellington M; de Jager M; Ive P; Mandaliya K; Stevens W; Steegen K; Nankya I; Boender TS; Ondoa P; Sigaloff KCE; de Wit TFR; Hamers RL
    AIDS; 2022 Aug; 36(10):1437-1447. PubMed ID: 35608116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of suboptimal immune recovery among a Chinese Yi ethnicity population with sustained HIV suppression.
    Chen L; Liu CH; Kang S; Du L; Ma F; Li C; Bai L; Li H; Tang H
    BMC Infect Dis; 2022 Feb; 22(1):137. PubMed ID: 35135485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
    Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
    AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of schistosomiasis on the outcome of patients infected with HIV-1 starting antiretroviral therapy in rural Tanzania.
    Stete K; Glass TR; van Dam GJ; Ntamatungiro A; Letang E; de Dood CJ; Corstjens PLAM; Ndege R; Mapesi H; Kern WV; Hatz C; Weisser M; Utzinger J; Müller MC
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006844. PubMed ID: 30332404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure to achieve a CD4+ cell count response on combination antiretroviral therapy despite consistent viral load suppression.
    O'Connor JL; Smith CJ; Lampe FC; Hill T; Gompels M; Hay P; Chadwick D; Fisher M; Ainsworth J; Gilson R; Mackie N; Anderson J; Orkin C; Nelson M; Kegg S; Leen C; Palfreeman A; Post F; Johnson M; Sabin CA; Phillips AN;
    AIDS; 2014 Mar; 28(6):919-24. PubMed ID: 24335482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 count recovery and associated factors among individuals enrolled in the South African antiretroviral therapy programme: An analysis of national laboratory based data.
    Kufa T; Shubber Z; MacLeod W; Takuva S; Carmona S; Bor J; Gorgens M; Pillay Y; Puren A; Eaton JW; Fraser-Hurt N
    PLoS One; 2019; 14(5):e0217742. PubMed ID: 31150489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
    He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
    PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents.
    Krogstad P; Patel K; Karalius B; Hazra R; Abzug MJ; Oleske J; Seage GR; Williams PL; Borkowsky W; Wiznia A; Pinto J; Van Dyke RB;
    AIDS; 2015 Mar; 29(6):683-93. PubMed ID: 25849832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The risk factors for suboptimal CD4 recovery in HIV infected population: an observational and retrospective study in Shanghai, China.
    Zhang F; Sun M; Sun J; Guan L; Wang J; Lu H
    Biosci Trends; 2015 Oct; 9(5):335-41. PubMed ID: 26559026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal dysfunction by baseline CD4 cell count in a cohort of adults starting antiretroviral treatment regardless of CD4 count in the HIV Prevention Trials Network 071 [HPTN 071; Population Effect of Antiretroviral Therapy to Reduce HIV Transmission (PopART)] study in South Africa.
    Bock P; Nel K; Fatti G; Sloot R; Ford N; Voget J; Gunst C; Grobbelaar N; Louis F; Floyd S; Hayes R; Ayles H; Beyers N; Fidler S;
    HIV Med; 2019 Jul; 20(6):392-403. PubMed ID: 30963667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid CD4 decline prior to antiretroviral therapy predicts subsequent failure to reconstitute despite HIV viral suppression.
    Darraj M; Shafer LA; Chan S; Kasper K; Keynan Y
    J Infect Public Health; 2018; 11(2):265-269. PubMed ID: 28826735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic response to antiretroviral therapy by age among treatment-naive patients in Sub-Saharan Africa.
    Stafford KA; Magder LS; Hungerford LL; Guralnik JM; El-Kamary SS; Baumgarten M; Redfield RR
    AIDS; 2018 Jan; 32(1):25-34. PubMed ID: 29028658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term immunologic response to antiretroviral therapy in low-income countries: a collaborative analysis of prospective studies.
    Nash D; Katyal M; Brinkhof MW; Keiser O; May M; Hughes R; Dabis F; Wood R; Sprinz E; Schechter M; Egger M;
    AIDS; 2008 Nov; 22(17):2291-302. PubMed ID: 18981768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal immune recovery and associated factors among people living with HIV/AIDS on second-line antiretroviral therapy in central China: A retrospective cohort study.
    Zhu K; Xu Q; Ma Y; Li P; Jia H; Jiang Q; Wang Y; Wu Z; Wang D; Guo H; Jin Y
    J Med Virol; 2022 Oct; 94(10):4975-4982. PubMed ID: 35710693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.